Weiner David B. 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed Feb 28, 2025
Insider Transaction Report
Form 4
Weiner David B.
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-02-26−972→ 0 total→ Common Stock (972 underlying) - Exercise/Conversion
Common Stock
2025-02-26+972→ 83,481 total - Exercise/Conversion
Common Stock
2025-02-26+972→ 84,453 total - Exercise/Conversion
Restricted Stock Unit
2025-02-26−972→ 972 total→ Common Stock (972 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- [F2]Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.